AAV-Navβ1 gene therapy effectively reduces seizures and prolongs life in a mouse model of SCN1B-linked Dravet syndrome, ...

Cathy created the DeVon Antonio Staton or DAS Foundation Inc. On March 9, 2025, the nonprofit organization will award three ...

In exchange for $165 million, Biogen now has access to zorevunersen, a potential first-of-its-kind treatment for Dravet ...

Extensive genetic testing is recommended for all children with epilepsy, unexplained developmental delays, autism and ...

This article showcases a curated list of standout studies over the last week on topics such as cholesterol, GLP-1 drugs for ...